Business was booming for Swiss pharma giant Novartis in the second quarter of 2025 with 11% net sales growth riding strong ...

2022 marked the end of Novartis’ second three-year performance cycle under Narasimhan, who ascended from chief medical officer at the company to CEO in 2018. Novartis’ most recent performance ...

Novartis AG (NYSE:NVS) Q4 2022 Earnings Conference Call February 1, 2023 8:00 AM ET Company Participants Samir Shah - Global Head of Investor Relations Vasant Narasimhan - Chief Executive Officer ...